- Home
- SAIH vs COSM Comparison
SAIH vs COSM Comparison
Compare SAIH & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAIH
- COSM
- Stock Information
- Founded
- SAIH 2019
- COSM 2009
- Country
- SAIH Singapore
- COSM United States
- Employees
- SAIH N/A
- COSM N/A
- Industry
- SAIH
- COSM Other Pharmaceuticals
- Sector
- SAIH
- COSM Health Care
- Exchange
- SAIH NYSE
- COSM Nasdaq
- Market Cap
- SAIH 12.3M
- COSM 12.3M
- IPO Year
- SAIH N/A
- COSM 2013
- Fundamental
- Price
- SAIH $9.71
- COSM $0.49
- Analyst Decision
- SAIH
- COSM
- Analyst Count
- SAIH 0
- COSM 0
- Target Price
- SAIH N/A
- COSM N/A
- AVG Volume (30 Days)
- SAIH 47.0K
- COSM 158.6K
- Earning Date
- SAIH 04-28-2025
- COSM 08-18-2025
- Dividend Yield
- SAIH N/A
- COSM N/A
- EPS Growth
- SAIH N/A
- COSM N/A
- EPS
- SAIH N/A
- COSM N/A
- Revenue
- SAIH $5,543,000.00
- COSM $53,554,457.00
- Revenue This Year
- SAIH N/A
- COSM $28.14
- Revenue Next Year
- SAIH N/A
- COSM N/A
- P/E Ratio
- SAIH N/A
- COSM N/A
- Revenue Growth
- SAIH N/A
- COSM N/A
- 52 Week Low
- SAIH $3.00
- COSM $0.28
- 52 Week High
- SAIH $26.98
- COSM $1.58
- Technical
- Relative Strength Index (RSI)
- SAIH N/A
- COSM 58.83
- Support Level
- SAIH N/A
- COSM $0.43
- Resistance Level
- SAIH N/A
- COSM $0.50
- Average True Range (ATR)
- SAIH 0.00
- COSM 0.03
- MACD
- SAIH 0.00
- COSM 0.00
- Stochastic Oscillator
- SAIH 0.00
- COSM 87.95
About SAIH SAIHEAT LIMITED
Saiheat Ltd develops technologies for the Computing Center Ecosystem (ACCE), a next-gen computing center featuring high-performance servers, liquid cooling, and systems for capturing and recycling computing heat. It aims to reduce the carbon footprint of Bitcoin mining and AI operations. The Company has four reportable segments: equipment sales, hosting, mining pool business, and mining.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.